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This study analyzes data from 182 Comprehensive Combat and 
Complex Casualty Care (C5) amputee patients with the goal 
to better understand the factors that influence their care. 
The data was provided from the Navy Bureau of Medicine and 
Surgery while visiting the Naval Medical Center at  
San Diego. The analysis examines two response variables, 
opiate drug usage and duration in the C5 program, as a 
function of a number of exploratory variables, including 
patient demographics, injury type, and appointment 
statistics. Logistic and linear regression models are used 
for data analysis. The study concludes that an increase in 
attendance to physical therapy, occupational therapy, and 
pain management and rehabilitation appointments correlates 
with an increased likelihood in reduced opiate usage. The 
study also concludes that the percentage of cancelled 
appointments is positively associated with the amputee’s 
duration in the program for non-Caucasian patients, 
patients with an improvised explosive device injury, and 
amputees with an upper-extremity amputation or both a 
lower- and upper-extremity amputation. 
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In an effort to better understand the factors that 
influence the treatment effectiveness of combat casualty 
amputee patients, our study analyzes the data of 182 
amputee patients within the Comprehensive Combat and 
Complex Casualty Care (C5) program through the use of 
logistic and linear regression models. The analysis 
examines two response variables, duration in the program 
and opiate drug usage, as a function of patient 
demographics, injury type, and appointment statistics. In 
particular, we look at the following exploratory variables: 
patient race and age; presence of a traumatic brain injury 
and mental health condition; amputation caused by an 
improvised explosive device (IED) or not; number of patient 
medical conditions; number of follow-up surgeries; location 
of amputation; and the percentage of “no show,” 
“cancelled,” and “kept” patient rehabilitation 
appointments. 
The main results of our study show that: 
 An increase in attendance to physical therapy, 
occupational therapy, and pain management and 
rehabilitation appointments correlates to an 
increased likelihood of reduced opiate usage. 
 The estimated probability of a reduction in 
opiate usage is less likely as the patient ages 
and the number of primary medical conditions 
increases. 
 xvi 
 Patients without an IED injury spend more time in 
the program as the number of primary conditions 
increase. 
 Percentage of cancelled appointments is 
positively associated with the treatment duration 
of upper-body amputees, patients with both an 
upper and lower amputation, and amputations 
caused by an IED. 
 The number of follow-up surgeries, presence of a 
traumatic brain injury, and mental health 
condition did not have a significant impact on 
opiate usage or duration in the program. 
The results of our study and similar studies could be 
used for future meta-analysis work to determine if similar 
correlations are repeated in other Military Treatment 
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The Global War on Terrorism has subjected today’s 
military service members to more than a decade of 
deployments under Operation Iraqi Freedom (OIF), Operation 
New Dawn (OND) in Iraq, and Operation Enduring Freedom 
(OEF) in Afghanistan (2003 to present). While on 
deployment, many of those service members experience blast 
injuries, behavioral health-related issues, and trauma. 
Some of the most severely injured servicemen and women 
returning home today receive care through the Comprehensive 
Combat and Complex Casualty Care (C5) at the Naval Medical 
Center in San Diego, California (NMCSD). The C5 program 
offers state-of-the-art medical care, treatment, and health 
management services to severely wounded, ill, or injured 
patients, from medical evacuation through inpatient care, 
outpatient rehabilitation, and their eventual return to 
active duty or transition from the military (Naval Medical 
Center San Diego, C5, 2013). 
The C5 program components include: 
 Trauma service; 
 Orthopedics, reconstructive plastic surgery, and 
wound care; 
 Amputee care, prosthetics, and rehabilitation; 
 Physical, occupational, and recreational therapy; 
 Mental health assessment and care; 
 Traumatic Brain Injury (TBI) care; 
 Pastoral care and counseling; and 
 Family support and career transition services. 
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The United States Navy Bureau of Medicine and Surgery 
(BUMED) is interested in improving care delivery to all C5 
patients. This study focuses on care delivery specific to 
amputee patients and address which factors most influence 
their care. 
B. THE PURPOSE OF THE STUDY AND RESEARCH QUESTIONS 
The purpose of this study is to better understand the 
factors that influence treatment effectiveness of amputee 
patients in the C5 program. We can influence medical  
cost-saving initiatives and practices by analyzing the 
implications of treatment compliance, effective treatment 
programs, and understanding prescription drug utilization. 
This study answers the following research questions: 
 Do patient demographics and/or the amount of 
“kept” physical therapy, occupational therapy, 
and pain management and rehabilitation 
appointments correlate with reduced opiate usage 
in amputee patients during treatment? 
 Do patient demographics and/or percentage of 
cancelled appointments correlate with their 
duration in the C5 program? 
These research questions are answered by data analysis 
and logistic and linear regression models applied towards 
relevant C5 data. 
Implementing new ways to improve patient appointment 
compliance reduces medical waste and costs. For example, 
when a single patient misses their scheduled appointment, 
valuable physician time is wasted, necessary patient care 
is not delivered, and other patients are denied 
appointments at an earlier date. 
 3 
C. ORGANIZATION OF THE STUDY 
Chapter II provides background information on the 
medical implications of OIF, OND, and OEF, relevant C5 
program information, and a review of previous studies. 
Chapter III provides descriptive statistics of variables 
utilized in the study. Chapter IV covers the methodologies 
used, a description of the models, and results of the 
analysis. The final chapter presents a summary of the study 
and offers recommendations for further analysis. 
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II. LITERATURE REVIEW 
This chapter addresses the rising medical costs 
associated with OIF, OND, and OEF; the severe injuries and 
illnesses our soldiers returning home must overcome in 
order to acclimate back into society; and recent studies on 
amputee patient care, treatment, and the impact of 
long-term, prescription drug usage. We can influence 
medical cost-saving initiatives and practices, and 
understand the implications of treatment compliance, by: 
 studying the impact of “missed” appointments on 
patient care; 
 studying which treatment paths are the most 
effective; and 
 understanding prescription drug utilization. 
The goal is to accomplish all three of these while 
continuing to provide top-notch care to amputee patients. 
A. MEDICAL COST IMPLICATIONS FROM A DECADE OF WAR 
Bilmes (2013) shows that the Iraq and Afghanistan wars 
combined are predicted to cost between $4 trillion and  
$6 trillion, making the combination of these two wars the 
most expensive in U.S. history. Bilmes also states that 
long-term medical care and disability compensation for 
service members, veterans, and families; military 
replenishment; and the social and economic costs have yet 
to be paid. Furthermore, the study shows that the Tricare 
healthcare system, which provides coverage for military 
members and their dependents (including those service 
members injured while serving in war) is expected to 
increase from $18 billion a year in 2001 to $56 billion a 
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year in 2013. This expense accounts for 8% of the total 
U.S. defense budget. 
As healthcare costs continue to rise, a better 
understanding of the variables that most impact patient 
care can enable physicians and care givers to control 
costs, improve patient satisfaction, and influence 
healthcare reform and treatment. 
B. OIF, OND, AND OEF IN NUMBERS 
Over the past decade, there have been approximately 
51,325 service members wounded in action (WIA);  
5,289 killed in action (KIA); and 6,729 total deaths (see 
Table 1) (U.S. Department of Defense, 2013). A percentage 
of the WIA become combat casualty patients treated in the 
C5 program at NMCSD. The majority of battle-injury 
amputations occurred in OIF from 2003 through the first 
quarter of 2009 (Fischer, 2013). By the second quarter of 
2009, however, most major limb amputations were due to 
battle injuries in OEF (see Figure 1) (Fischer, 2013). 
UNITED STATES MILITARY CASUALTY STATUS* 
FATALITIES AS OF AUGUST 12, 2013 
OPERATION TOTAL DEATHS KIA NONHOSTILE WIA 
OIF 4,409 3,480 929 31,927 
OND 66 38 28 295 
OEF 2,254 1,771 483 19,103 
TOTALS 6,729 5,289 1,440 51,325 
 OIF includes casualties that occurred between  
March 19, 2003 and August 31, 2010. 
 OND includes casualties that occurred between  
September 1, 2010 and December 31, 2011. 
 OEF includes casualties in Afghanistan and other locations in support 
of OEF. 
Table 1.   U.S. military casualty status in numbers by 
the Department of Defense (After U.S. Department 
of Defense, 2013). 
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Figure 1.  Trend of major limb amputations from 
OIF/OND/OEF (After Fischer, 2013). 
The amputee population in our study includes many 
patients who suffer from a TBI. From the beginning, we 
believed that the presence of such an injury would impact 
our analysis; therefore, data on TBI was included in our 
study. Figure 2 displays the number of TBI diagnoses from 
2000 through 2013. The amount of amputee and TBI patients 
injured in combat will likely decrease as the United States 
withdraws from these armed conflicts. The medical care for 




Figure 2.  TBI diagnoses from OIF/OND/OEF (From Defense 
and Veterans Brain Injury Center, 2013). 
C. THE C5 PATIENT CARE PROCESS 
After a military member receives an amputation, they 
are assigned care in the C5 program (or similar military 
medical program). The process after assignment of C5 care 
was obtained from a personal communication with a Johns 
Hopkins University Applied Physics Lab analyst (J. P. 
Allred, personal communications, May 5, 2013) and is 
detailed in the remainder of this paragraph. Prior to the 
patient’s arrival, the critical care staff typically 
schedule a teleconference with the patient, the family, and 
critical staff members from the current Military Treatment 
Facility (MTF) servicing the patient. The teleconference 
consists of a “Question & Answer” session to relieve 
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patient/family anxiety about transferring into the NMCSD C5 
program. Upon arrival, the patient may spend from a single 
day up to two weeks in the in-patient ward. Here, the 
patient will be introduced to their C5 case manager/ 
in-patient social worker. Upon in-patient discharge and 
within the next 48 hours, the patient is seen by their 
Primary Care Manager (PCM). The PCM will then begin to 
manage and assess the patients’ medical needs, including 
referrals to numerous specialty care clinics, therapies, 
and physicians. 
D. PREVIOUS STUDIES 
The research in our study aims at analyzing treatment 
effectiveness for amputee patients in the C5 program. This 
research task is very focused. While few studies were found 
that directly impact the research direction, there are 
several related works relevant to this study. This section 
is broken into four distinct literature subgroups, and 
addresses the relationship between each literature subgroup 
and relevance to our study. 
1. Resource Utilization, Treatment, and Clinical 
Outcomes of Amputee Patients 
Understanding which variables influence a patients’ 
ability to heal more quickly (e.g., the location of the 
amputation, medication prescribed to manage pain, magnitude 
of preexisting or current injuries, and cause of injury), 
allows for more effective and appropriate utilization of 
resources and improvement in combat casualty care  
of patients. 
Shin, Evans, and Fleming (2012) examined resource 
utilization in combat-related amputations from OEF and OIF 
 10 
by Injury Severity Score (ISS). The ISS is associated with 
the number of extremities amputated, number of associated 
injuries, utilized blood products, intensive care unit 
length of stay (ILOS), and hospital length of stay (HLOS) 
in those with an upper-extremity amputation (UEA), compared 
to those with an isolated, lower-extremity amputation 
(LEA). Shin et al. (2012) note that amputee battle injury 
patterns result from a significant increase in the 
frequency of high-energy blast mechanisms; in particular, 
improvised explosive devices (IEDs), which lead to more 
severe and complex injuries. 
The study by Shin et al. (2012) included 102 male 
Marines with a mean age of 24.3 years. The majority of the 
injuries were a result of high-energy blasts; however, the 
presence of a high-energy blast injury was not a 
significant factor between the two groups (UEA versus LEA). 
UEA, however, was associated with increased blood product 
utilization, ILOS, and increased HLOS. The difference in 
the ISS between UEA and LEA patients was not significant. 
The severity of the injury and resource utilization was 
underestimated by the ISS in patients with combat-related 
amputations. 
Melcer, Walker, Sechriest II, Galarneau, Konoske, and 
Pyo (2013) compared the clinical outcomes of combat amputee 
patients to those patients who did not sustain an 
amputation injury during Iraq and Afghanistan deployments. 
Amputee patients had a significantly lower follow-up rate 
within 18-24 months of their post-injury treatment, and a 
significantly higher complication rate than patients 





 Heterotopic Ossification; 
 Septicemia; 
 Deep Vessel Thrombosis; and 
 Pulmonary Embolism. 
Furthermore, amputees display an increased rate of 
mental health issues such as nonorganic sleep, pain, and 
post-concussion syndrome. Post-Traumatic Stress Disorder 
(PTSD) rates were found to be relatively low among amputee 
patients, whereas age, TBI, mechanism of injury, and injury 
year were significantly associated with the health outcomes 
within these two groups. The study concluded that medical 
care of amputee patients should focus on aggressive 
infection control and wound management practices, as well 
as early interaction of behavioral health services to 
mitigate the effects of mental health disorders. 
Tintle, Baechler, Nanos, Forsberg, and Potter (2012) 
hypothesized that current revision rates among UEA patients 
are higher than existing literature would suggest, and that 
surgical treatment of complications and persistent symptoms 
would lead to improved outcomes in health. The study 
included 100 major UEAs from OIF and OEF. All amputations 
resulted from high-energy trauma such as blast injury. 
Forty-two percent of the patients underwent repeat surgical 
interventions, 27% remained on opiate pain medication, and 
28% remained on nonopioid, antineuropathic pain 
medications. The authors were unable to conclude if 
surgical intervention improved chronic pain levels. 
Moreover, the level of amputation did not correlate with 
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the presence of limb pain, opioid pain usage, or return to 
duty. However, phantom limb pain and the use of neuropathic 
pain medications were correlated. 
In our study, the amputation population has similar 
characteristics to the 2012 study by Tintle et al., 
including injuries caused by IEDs, opiate usage, and 
repetitive surgical intervention. 
2. Influence of “Missed” Appointments on Patient 
Care 
Our study shows that “cancelled” appointments impact 
the patient’s duration in the C5 program, which indirectly 
increases medical costs through wasted physician man-hours 
and more days of patient treatment. The studies below 
address implications, consequences, and medical costs 
associated with a patient’s failure to comply with 
scheduled medical appointments. 
When patients fail to show up for appointments, the 
medical facility’s operational efficiency can be greatly 
reduced (Bertrand, 2000). Providers cannot efficiently 
treat their patients, and resources are underutilized or 
wasted while untreated conditions worsen (Bertrand, 2000). 
Furthermore, missed appointments disrupt patient-provider 
relationships and deny other patients access to medical 
care. When appointments are not readily available to 
military members, these patients are referred to the 
network providers, which is a substantial cost burden to 
the military healthcare system. Improving appointment 
compliance can improve patient care, satisfaction, and also 
reduce costs (Bertrand, 2000). 
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Nguyen, DeJesus, and Wieland (2011) examined missed 
appointments in a Resident Continuity Clinic of 325 
patients who received five or more office visits between 
2006 and 2008. Prior research has shown that patients who 
frequently miss appointments tend to be younger, of lower 
socioeconomic status, have a history of missed 
appointments, and have government-provided insurance. In 
their study, patient factors associated with a higher 
frequency of missed appointments were Medicaid insurance, 
more frequent emergency department visits, and the use of a 
medical interpreter. Those patients who had a higher 
proportion of office visits with their primary care 
provider were found to have a lower frequency of missed 
appointments. Moreover, the authors note that a high rate 
of missed appointments could possibly be used as an 
indicator of self-care and may help identify those patients 
who would benefit from case management services that focus 
on adherence to treatment plans. 
3. Understanding Amputee Medical Care and the 
Importance of Rehabilitation Delivery to These 
Patients 
This section details the patient-physician goals 
associated with physical therapy (PT) and occupational 
therapy (OT) appointments. Our study analyzes the 
association between PT/OT appointments and pain management. 
Therefore, we would like the reader to understand the goals 
associated with these forms of therapy and why they are 
important to amputee recovery. 
In the Harvey et al. (2012) study, they address the 
current atmosphere of battle amputations and detail the 
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treatment of amputee patients. The following information 
summarizes their study. 
Improvement in body armor and rapid medical 
evacuation, combined with battlefield medicine and modern 
resuscitation techniques, have led to increased survival 
rates among military service members who have sustained 
severe, combat-related injuries. As of December 2011, 
nearly 1,400 service members have suffered a major limb 
amputation as a result of a combat wound sustained in Iraq 
and Afghanistan. To promote improved long-term 
functionality, every effort is made to preserve limb 
joints. This often requires creative skin grafts or muscle 
flaps that may prolong healing and delay prosthetic fitting 
and training. Implementing early rehabilitation is vital to 
promoting range of motion (ROM) and prevention of joint and 
soft tissue contractures. Achieving adequate pain control 
is also extremely important; pain management techniques 
such as continuous regional anesthesia, epidural blocks, 
patient-controlled analgesia, and oral medications, as well 
as heat, ice, massage, and electrical stimulation therapies 
are utilized. To promote a patient’s ability to participate 
in therapy, premedication with short-acting opioids prior 
to therapy is sometimes employed. Furthermore, the presence 
of TBI and/or psychological health problems (e.g., anxiety, 
depression, PTSD) significantly interfere with the 
patient’s ability to follow directions, attend to tasks, 
and show steady learning techniques. 
The role of PT is to return the patient to their 
highest level of attainable physical function. To optimize 
the success of UEA patients, rehabilitation should begin as 
soon as possible, while focusing on conditioning critical 
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core muscles on all planes to allow proper prosthetic use 
and trunk stability. Patients with bilateral lower 
extremity loss can be fitted with shorter prosthetics to 
lower their center of mass to promote gait and balance 
mastery. PT also includes cardiovascular conditioning to 
improve endurance and maintain weight control. 
The goal of OT is to return each patient to their 
highest possible level of independence and function in 
performing activities of daily living (ADL), with and 
without a prosthesis. ADL includes activities such as 
eating, grooming, dressing, bathing, toileting, transfers, 
and wheelchair positioning and mobility. 
4. Adverse Impact of Opiate Medication on Patient 
Care 
Our amputee population was dispensed over 3,000 opiate 
medications during their treatment phase. Our study 
analyzes the association between PT/OT appointments and 
opiate usage. 
In Trevino, deRoon-Cassini, and Brasel’s (2013) study, 
they examined opiate medication usage for the treatment of 
chronic pain in 101 single, level-1 trauma patients at four 
months posttrauma. Seventy-nine percent of those patients 
developed chronic pain post-trauma and, of those, 26% were 
still utilizing opiate medication. Those patients medicated 
with narcotics at four months posttrauma had significantly 
more depression, anxiety, life interference, and pain. 
Relief of pain was not significantly related to opiate 
usage. 
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E. CHAPTER CONCLUSION 
Our study looks at similar exploratory variables of 
amputee patients (percentage of “cancelled” and “no show” 
appointments, IED injuries, TBI, etc.) and analyze their 
association to treatment outcomes. Chapter III outlines the 
data and models analyzed in the study, as well as provide 
descriptive statistics of the variables. 
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III. DATA AND DESCRIPTIVE STATISTICS 
A. INTRODUCTION 
This chapter outlines the data analyzed in the study, 
the data-cleaning techniques utilized, a description of 
variables examined, and basic descriptive statistics. The 
exploratory variables outlined in this chapter are analyzed 
in two different models in Chapter IV. The  
two models answer the following questions: 
 Model 1: Do patient demographics and/or the 
amount of “kept” PT, OT, and Pain Management and 
Rehabilitation (PM&R) correlate with reduced 
opiate usage in amputee patients during 
treatment? 
 Model 2: Do patient demographics and/or 
percentage of “cancelled” appointments correlate 
with their duration in the C5 program? 
Each model has a response variable: 
 Model 1: Reduction in opiate usage; and 
 Model 2: Duration in the C5 program 
There are also 11 exploratory variables: 
 Percentage of “no show” appointments; 
 Mechanism of injury; 
 Presence of TBI; 
 Presence of mental health condition; 
 Race; 
 Number of primary conditions; 
 Number of follow-up surgeries; and 
 Percentage of “kept” PT/OT/PM&R appointments. 
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 Percentage of “cancelled” appointments 
 Age upon entry into the C5 program 
 Location of amputation 
The response and exploratory variables are discussed 
in Sections C and D of this chapter, respectively. Each 
section includes a brief description of the variable, 
descriptive statistics on the variable, and a distribution 
of the population represented by a bean-plot or another 
visual figure. 
B. DATA SOURCE 
The data used for this study was obtained from BUMED. 
The data contains information on C5 amputee patients 
between 2002 and 2012. The data were dispersed across 
multiple Excel spreadsheets and included information on: 
 Patient Referrals; 
 Patient Appointments; 
 Medical Board Status; 
 Surgical Interventions; 
 Prescription Orders; and 
 Patient Admissions. 
Patients are identified by unique patient Episode 
Identification (ID) to ensure patient confidentiality. 
Patient data from multiple Excel spreadsheets were combined 
by Episode ID. Amputee patient data was extracted by the 
listed primary diagnosis code “1.” This code implies that 
the patient had an amputation. This condition was verified 
by the primary diagnosis free text cell (doctor notes). 
Appointment percentages, surgical procedures, and primary 
condition counts were extracted through the use of pivot 
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tables in Excel. Medical board data, which were later used 
in determining the patients’ approximate end date (later 
referred to as Episode End Date) were extracted and 
compared from discharge dates provided and free text 
“dictation edit results.” Lastly, the data were combined 
into usable common separated values (CSV) files for  
R programming. 
C. RESPONSE VARIABLES 
There are two response variables used in the analysis 
for the models shown in Chapter IV. The response variable 
name and model in which it will be used is shown in  
Table 2. A description of each variable and summary 
statistics follows. 
RESPONSE VARIABLE NAME MODEL USED 
Reduction in Opiate Usage 1 
Duration in the C5 Program 2 
Table 2.   Mapping of response variables to Models 1 
and 2. 
1. Reduction in Opiate Usage 
Model 1 addresses the question: Do patient 
demographics and/or the amount of “kept” PT, OT, and PM&R 
appointments correlate with reduced opiate usage in amputee 
patients during treatment? The response variable used in 
this model is a binary response variable; 1 indicates 
significant reduction in opiate usage and 0  
if not. 
In Model 1, the raw data include 236 amputee patients. 
Of those, 186 patients completed the C5 program with PT, 
OT, and/or PM&R appointments. We restrict the patients to 
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those with at least three prescribed and dispensed opiate 
medications within their treatment period, bringing the 
patient count to 157. These patients were used in the 
Opiate Log-Regression Model. 
The response variable “Opiate Reduction” is derived 
from a simple linear regression model where “Quantity of 
Medication Dispensed” was regressed over “Days from Episode 
Start Date” in the C5 program by Episode ID. Of the 3,510 
opiate prescriptions filled, 406 of them were not dispensed 
to the patient. This implies an estimated patient 
prescription compliance rate of 88%. The software package R 
was used for all regressions. 








































1 5/15/12 5/15/12 1/27/2012 109 
Table 3.   Sample of Opiate prescription data for 
patient 1. 
To determine if the patient significantly reduces 
their opiate usage over the course of the treatment phase, 
column two (QTY) and eight (DAYS FROM START) were 
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regressed. Notice that row one is not included in the 
analysis because the prescription is not dispensed to  
the patient. 
Table 4 displays the result of the simple linear 
regression (Appendix A contains R-code and output). 
REDUCTION IN OPIATE USAGE 
OUTCOME PATIENT COUNT 
YES, SIGNIFICANT REDUCTION(1)* 123 
NO, SIGNIFICANT REDUCTION(0)* 34 
*LM (QTY ~ Days From Episode Start Date) 
Null Hypothesis (H0): β0 < 0, where β0 represents the slope 
of the regression line. 
YES, there is evidence to suggest that opiate usage declined 
over patient duration in the program = 1) 
Alternative Hypothesis (HA): β0 ≥ 0 
NO, there was not significant evidence to suggest that 
opiate usage declined over patient duration in the program  
= 0) 
Fail to Reject H0 (interpretation): There is not significant 
evidence to suggest that β0 is greater than or equal to 
zero. 
(See Appendix A for simple linear regression R-code.) 
Table 4.   Simple linear regression of opiate reduction 
and patient count of regression outcome. 
2. Duration in the C5 Program 
Model 2 addresses the question: Do patient 
demographics and/or percentage of cancelled appointments 
correlate with their duration in the C5 program? The 
response variable, “Duration in the C5 Program,” used in 
this model is an integer variable defined by the difference 
of a patient’s “Episode End Date” and their “Episode Start 
Date.” Table 5 provides an example of the data. Patient 1 








DURATION IN THE 
PROGRAM (DAYS) 
1 1/27/2012 11/19/2012 297 
Table 5.   Sample calculation of duration in the 
program data for patient 1. 
The “Episode Start Date” was modified to reflect the 
earliest date between the “Given” Episode Start Date (the 
data supplied by the data file) and “Initial Appointment 
Date” of the individual patient. The average difference 
between the “Given” and “Modified” Episode Start Dates is 
approximately 24 days (less than one month). The “Episode 
End Date” was modified to reflect the latest date between 
the “Given” Episode End Date and the latest date noted from 
Medical Evaluation Board (MEB) Evaluation End Date, MEB End 
Date, Final Disposition Date, Final Disposition Date, Date 
Final Out-Processing Complete, or Date of Separation on the 
DD214. The average difference between the “Given” and 
“Modified” end date is 72 days (approximately 2½ months). 
Initially, 137 amputee observations had “Given” Episode End 
Dates; but, by modifying the Episode End Dates, 49 
additional observations were employed. Four patients had to 
be eliminated due to missing data, so the final population 
size was 182 patients. 
Figure 3 presents summary statistics and distribution 
associated with the patient duration variable. On average, 
amputee patients are in the program for 538 days. A bean 
plot of the patient duration data is also shown in  
Figure 3. As an alternative to a box plot, a bean plot 
shows the individual observations as horizontal lines. The 
density of the data is illustrated by the width of the 
polygon. The horizontal distance represents the frequency 
of a specific observation and the bold, horizontal line 
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represents the mean of the data. A large proportion of the 
population is distributed between 475 to 600 days, with an 
average of 538. 







Statistics were produced 
in R 
 
Figure 3.  Distribution of patient duration in the  
C5 program. 
D. EXPLORATORY VARIABLES 
There are 11 variables used in the analysis to fit the 
models shown in Chapter IV. The exploratory variable name 
and the model in which it is used are shown in Table 6. A 




VARIABLE EXPLORATORY VARIABLE NAME 
MODEL 
USED 
1 Percentage of “no show” appointments 2 
2 Mechanism of Injury: IED 1, 2 
3 Indicator: TBI 1, 2 
4 Indicator: Mental Health Condition 1, 2 
5 Race 1, 2 
6 Number of Primary Conditions 1, 2 
7 Number of Follow-Up Surgeries 1, 2 
8 Percentage of “kept” PT/OT/PM&R appointments 1 
9 Percentage of “cancelled” Appointments 2 
10 Age Upon Entry into the C5 Program 1, 2 
11 Location of Amputation 1, 2 
Table 6.   Mapping of exploratory variables to Models 1 
and 2. 
1. Percentage of “No-Show” Appointments (Variable 1) 
The exploratory variable percentage of “no show” 
appointments is a continuous variable defined by those 
appointments that were scheduled and missed, but not 
previously cancelled, divided by the total number of 
scheduled appointments. Table 7 provides an example of 
patient appointment data. In this example, patient 1 did 
not show up for one of six appointments per the data below; 
therefore, patient 1 has a “no show” percentage of 17%, a 




































Table 7.   Sample of percentage of “no show” 
appointment data for patient 1. 
Figure 4 presents descriptive statistics and a bean 
plot of percentage of “no show” data. Of 182 patients, the 
average patient missed 7.4% of their scheduled 
appointments. 
PERCENTAGE OF PATIENT 
APPOINTMENTS THAT WERE 








Statistics were produced  
in R 
 
Figure 4.  Descriptive statistics on percentage of  
“no show” appointments. 
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2. Binary Variables (Variables 2, 3, 4, and 5) 
Mechanism of injury is the “cause” of injury to the 
patient. This variable is divided into two groups, a 
patient who was strictly classified as having an injury 
caused by an IED or not. If the injury to the patient is 
not caused by an IED, it falls under the “other” category. 
The “other” category includes injuries caused by motor 
vehicle accidents, medical necessity, a fall, airplane 
crash, gunshot wound, crush wound, grenade, or Not 
Available (NA). 
TBI is a condition that results from a violent blow or 
trauma of the head or body, or skull penetration. TBI can 
cause mild to major brain dysfunction (Mayo Clinic, 2012). 
Approximately 65% of the amputee patients have an 
amputation caused by an IED blast, 40% have a TBI-related 
injury, two patients have a diagnosed mental health-related 
issue, and 63%-65% of the patient population is Caucasian. 
A mental health condition includes PTSD and non-PTSD 
related issues such as sexual abuse, depression, anxiety, 
addition, and suicidal ideologies. Non-Caucasian patients 
include the races of Hispanic, African-American, Asian, 
American Indians, and unknown (one patient was in this 
category). Table 8 depicts the number of patients who have 
an amputation caused by an IED, a TBI-related injury, a 
mental health condition, or are Caucasian for each model. 
Recall that Model 1 includes 157 amputee patients who were 
prescribed and dispensed at least three opiate medications, 
whereas Model 2 has 182 patients because opiate usage is 
not included in this model. 
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PRESENCE OF CONDITION OR PATIENT CHARACTERISTIC (Count) 
CONDITION OR CHARACTERISTIC Model 1 Model 2 
Yes, presence of IED injury (1) 102 119 
Yes, presence of TBI (1) 63 72 
Yes, presence of Mental Illness (1) 2 2 
Yes, patient is Caucasian (1) 103 116 
 
Table 8.   Summary statistics on presence of patient 
condition or characteristic. 
To ensure that patients were correctly classified, 
patient indicators were verified by comparing primary ID 
codes to primary diagnosis free text cells to ensure that 
patients were identified correctly. Table 9 provides an 





PRIMARY DIAGNOSIS FREE TEXT 
1 12 Depressed fracture 
Table 9.   Sample of a primary diagnosis ID and free 
text diagnosis for patient 1. 
The primary diagnosis ID value of 12 implies that the 
patient has a mental health condition that is not PTSD, 
such as depression. From the free-text diagnosis, we can 
see that the patient does not have depression, but a 
depressed fracture. Therefore, the patient should not have 
an indicator of 1 for a mental health condition. 
3. Number of Primary Conditions (Variable 6) 
Primary conditions include the following injuries: 
amputation, back injury, burn, fracture, genitourinary 
injury, gunshot wound, medicine, multilimb fracture, 
musculoskeletal injury, nerve damage, PTSD, penetrating 
wound, non-PTSD mental health conditions, TBI, and wounds 
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not otherwise classified (Wound Not Elsewhere Classified 
[NEC]). A single primary condition represents an amputee 
patient. Figure 5 presents descriptive statistics and a 
bean plot of the count of patient primary conditions. The 
average amputee patient has three primary conditions: the 
presence of an amputation with two other health conditions. 
NUMBER OF PRIMARY CONDITIONS 
 
STATISTIC Model 1 Model 2 
MINIMUM 1 1 
MEDIAN 3 3 
MAXIMUM 7 7 
MEAN 2.682 2.687 
STANDARD DEV. 1.316 1.357 
Statistics were produced in R 
 
Figure 5.  Descriptive statistics on the number of 
primary conditions seen in the amputee patients. 
4. Follow-Up Surgeries within the C5 Program 
(Variable 7) 
Follow-up surgeries are those surgeries incurred after 
the patient has been admitted into the C5 program.  
Figure 6 provides descriptive statistics and a bean plot of 
the number of patient follow-up surgeries. The average 
amputee patient undergoes between one and two additional 
surgeries during their treatment time in the C5 program. 
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Model 1 Model 2 
MINIMUM 0 0 
MEDIAN 1 0 
MAXIMUM 10 10 
MEAN 1.783 1.621 
STANDARD DEV. 2.357 2.287 
Statistics were produced in R 
 
Figure 6.  Descriptive statistics on the number of 
follow-up surgeries required by amputee patients 
in the C5 program. 
5. Percentage of “Kept” PT, OT, and PM&R 
Appointments (Variable 8) 
A “kept” appointment includes all PT, OT, and PM&R 
appoints that were scheduled and not missed due to a 
cancellation or a “no-show.” The percentage of kept 
appointments is the total “kept” appointments scheduled 
divided by the total (“kept,” “cancelled,” and “no-show”) 
appointments scheduled. In Figure 7, the average amputee 
patient kept approximately 74% of their scheduled PT, OT, 
and PM&R appointments. 
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“KEPT” PT/OT/PM&R APPOINTMENTS 
 





STANDARD DEV. 12.38% 
Statistics were produced in R 
 
Figure 7.  Descriptive statistics on the percentage of 
“kept” PT, OT, and PM&R appointments. 
6. Percentage of “Cancelled” Appointments  
(Variable 9) 
This variable is defined by those appointments that 
were scheduled, but cancelled prior to the scheduled 
appointment, divided by the total number of scheduled 
appointments. Of 182 patients, (four additional patients 
were omitted due to missing data) the average patient 
cancelled 17.15% of their scheduled appointments (see 
Figure 8). The data are not sufficiently robust to support 
a clear distinction between the definition of a “cancelled” 
appointment and a “no show” appointment; e.g., many 
“cancelled” appointments were terminated on the same day or 
within the same hour of the scheduled appointment. 
Appointment status is manually entered; therefore, the 
presence of human error could bias the impact of “no show” 
rates if appointments were noted as “cancelled,” but were 
truly a “no show.” 
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PERCENTAGE OF “CANCELLED” 
APPOINTMENTS 
 





STANDARD DEV. 7.249% 
Statistics were produced in R 
 
Figure 8.  Descriptive statistics on the percentage of 
cancelled appointments. 
7. Age upon Entry into the C5 Program (Variable 10) 
The patient’s age is defined as the difference between 
the patient’s date of birth and the patient’s modified 
episode start date. Table 10 provides an example of how a 
patient’s age was calculated. 
EPISODE ID EPISODE START DATE DATE OF BIRTH AGE 
1 1/27/2012 12/22/1978 33 
Table 10.   Sample calculation of age for Patient 1. 




PATIENT’S AGE  




Model 1 Models 2 and 3 
MINIMUM 19 19 
MEDIAN 23 23 
MAXIMUM 60 60 
MEAN 24.79 24.86 
Statistics where produced in R 
 
Figure 9.  Descriptive statistics on the patient’s age 
at the time of entry into the C5 program. 
8. Location of Amputation (Variable 11) 
Of the 182 amputee patients, 150 of them have 
amputations of their lower body area, 19 have amputations 
of their upper-body extremity area, and 13 patients have 
amputations of both the upper and lower body. A lower-body 
amputation includes an amputation of the hip, knee 
disarticulation, above or below the knee, ankle joint, 
partial foot, or toe. Upper-body amputation includes an 
amputation above or below the elbow, shoulder 
disarticulation, wrist, or finger. Furthermore, 125 of the 
182 patients have one amputation site, 47 have two 
amputation sites, 9 have three amputation sites, and 1 
patient has four. For this study, we focus on the breakdown 
shown in Figure 10; however, Figure 11 provides additional 















Table 11 provides descriptive statistics on the count 
of amputations per patient. 
 






STANDARD DEVIATION 0.6065 
*Count represents number of amputee sites per patient; some 
patients had multiple amputees on one or both sides of their 
upper/lower body (statistics produced in R). 
Table 11.   Descriptive statistics on the number of 
amputations per patient. 
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IV. ANALYSIS 
A. MODEL 1 
Do patient demographics and/or the amount of “kept” 
PT, OT, and PM&R appointments correlate with reduced opiate 
usage in amputee patients during treatment? 
1. Analytical Method 
Model 1 analyzes the relationship between patient 
demographics; the amount of PT, OT, and PM&R appointments; 
and patient opiate usage. In particular, we would like to 
see if a correlation exists between demographics or patient 
therapy appointments and a patient’s ability to cope with 
pain, measured by a reduction in opiate usage during 
treatment. We use a logistic regression model because the 
dependent variable, “reduction in opiate usage during 
treatment” is binary. Let    be a random variable indicating 
if there is a significant reduction in patient     opiate 
usage (1 if significant reduction, 0 otherwise). Let    be 
the probability that patient   exhibits a significant 
reduction in opiate usage. Chapter III, Section C.1 
explained how a reduction in opiate usage during treatment 
(  ) was calculated. 
In a logistic regression, the relationship between the 
predictor and response variables is not a linear function; 
instead, the logistic regression function is utilized by a 
logit transformation of    (e.g., World Bank, 2010). 
The theoretical model is: 
              
                 
                    




               
  
      





   
  
    
                                                     
 
                                                                               
                                            
 
             
 
                                                   
 
                                  
 
The coefficients in the model represent the change in 
the log-odds for a unit change in an   . The    captures the 
various characteristics for the individual patients (this 
includes demographics and percentage of “kept” 
appointments). Variable descriptions are displayed in Table 
6. 
We define the odds ratio of an exploratory variable s 
as       
  . If the odds ratio for the variable mental 
health (M_HEALTH) (             
         ) equals 1, it is an 
indication that a patient with a mental health condition is 
equally likely to either reduce or not reduce their opiate 
usage. An            greater than 1, however, indicates a 
higher likelihood of the patient reducing opiate usage than 
not. Finally, an            less than 1 indicates a lower 
likelihood of a patient reducing opiate usage than not. 
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2. Analysis/Validation 
Model 1 is developed by fitting the data using a 
Generalized Linear Model (GLM) in R. Several models are fit 
utilizing the StepAIC (stepwise regression using Akaike 
Information Criterion) function with main effects and two-
way interactions of exploratory variables. A mixed stepwise 
regression is used in combination with several different 
starting and ending criteria in order to find the best 
model (see Appendix B for the R-code). 
Table 12 shows the regression coefficient estimates 
(    ) for each of the terms in the model, as well as the 
statistics associated with the hypothesis test for those 
terms. A factor is significant if the p-value is less than 
or equal to 0.05. 
TERM Estimate Std. Error z value Pr(>|z|) 
INTERCEPT -11.37162 4.39121 -2.590 0.00961** 
AGE_ENTRY 0.41635 0.17326 2.403 0.01626* 
NUM_PRIMARY 2.03794 1.05483 1.932 0.05336. 
PER_KEPT 0.04074 0.01715 2.375 0.01754* 
CAUCASIAN_1 7.20007 2.82198 2.551 0.0173* 
AGE_ENTRY: 
CAUCASIAN_1 
-0.26966 0.11649 -2.315 0.02065* 
AGE_ENTRY: 
NUM_PRIMARY 
-0.09379 0.04358 -2.152 0.03138* 
Significance level: 
‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 
Table 12.   Model 1 with interaction terms  
and statistics. 
The patient’s age and race; number of primary 
conditions; percentage of “kept” OT, PT, and PM&R 
appointments; and interaction of the patient’s age with 
race and number of primary conditions were found to be 
significant model terms. The final model can be expressed 
in Equations 2 and 3: 
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The percentage of “kept” appointments is the only 
variable not involved in the interaction that is 
significant, with a beta coefficient of 0.0407 and an odds 
ratio value of 1.04 (       ). This value implies that a 
higher percentage of “kept" appointments is correlated with 
an increase in the odds of reducing opiate usage. 
As an example of using the logistic regression 
equation, a 25–year-old Caucasian patient who has three 
primary conditions and maintains 74% of their PT, OT, and 
PM&R appointments results in an estimated probability of 




    
    
       
  
 
        
 
                                                                
                                            
                              
 
                                                                
                             
 
          
Figure 12.  Estimated probability of a 25-year-old 
Caucasian patient with three primary conditions 
who kept 74% of their PT, OT, and PM&R 
appointments. 
Thus,    = 0.877, and to classify    as    = 1 or 0, a 
threshold value must be selected. The selection criteria is 
discussed below. 
In a binary classification test each patient ends up 
in one of the four possible states: True Positive, False 
Positive, True Negative, and False Negative (Fricker, 
2013). In our case, the following is the interpretation of 
these states: 
 True Positive (TP): A patient reduces their 
opiate usage and is correctly classified by  
the model. 
 False Positive (FP): A patient does not reduce 
their opiate usage, but the model incorrectly 
classifies them as reducing their opiate usage. 
 True Negative (TF): A patient does not reduce 
their opiate usage and is correctly classified by 
the model. 
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 False Negative (FN): A patient reduces their 
opiate usage, but the model incorrectly 
classifies them as not reducing their  
opiate usage. 
We identify an FP as a more severe misclassification 
than an FN. The patients falling into this category could 
require more care and case management to progress in the C5 
program. Since these patients are classified incorrectly, 
however, their needs may go unidentified. 
Figure 13 demonstrates FP and FN values at varying 
thresholds. Initially, the threshold is set at 0.5, which 
implies that for any    > 0.5, the patient is classified as 
a    = 1. As the threshold values reduce from 0.9 to 0.5, 
the likelihood of predicting that an amputee patient 
reduces their opiate medication when, in reality, they 
actually did not (FP) increases, whereas the FN value 
decreases (predicts that a patient does not reduce their 
opiate usage, but, in reality, they did). 
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Figure 13.  Variation of reduction in opiate usage 
prediction at varying threshold values. As the 
threshold values reduce from 0.9 to 0.5, the 
likelihood of predicting an FP increases, whereas 
FN decreases. 
From Figure 13, we determined that an acceptable FP is 
at or below 0.4. To maintain an FP rate of 0.4, the 
threshold value lies between 0.70 through 0.80. 
Utilizing the Cross-Validation Generalized Linear 
model (cv.glm) in R, the data is randomly divided into K 
groups. K splits are found by randomly partitioning the 
data into K groups of approximately equal size (Davison, 
1997). The cv.glm function calculates the estimated K-fold 
cross-validation (CV) prediction error for a GLM. 
Table 13 provides the corresponding threshold value to 
its FP, misclassification rate (MR), CV, and the difference 
of the MR to its CV. We would like a minimal difference 
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between the MR and CV. We select a threshold value of 0.76, 
as it results in an FP close to 0.4, with a minimal 











(CV – MR) 
0.75 0.44 0.312 0.32 0.008 
0.76 0.41 0.318 0.32 0.002 
0.77 0.38 0.312 0.35 0.038 
0.78 0.38 0.331 0.37 0.039 
Table 13.   Varying threshold values with corresponding 
FP, MR, and CV rates. 
The calculated cross-validation value at a threshold 
of 0.76 is 0.32, with 10 folds. The misclassification and 
cross-validation values are approximately the same (see 
Figure 14 and Appendix B). Table 13 and Figure 14 shows 
that our model, even out of sample and using the 
significant patient characteristics, (1) accurately 
classifies about 70% of patients between reducing opiate 
usage and not, and (2) it keeps the false positive rate at 
or below 0.4. 
Misclassification Matrix 






0 - No TN = 20 FP = 14 
1- Yes FN = 36 TP = 87 
 
Figure 14.  Misclassification matrix and calculation. 




3. Results and Discussion 
While our model does not prove causation, it does 
allow us to classify the odds that a patient reduces their 
opiate usage based on Equations 1 and 3. An example 
calculation of    was shown in Figure 12, resulting in a pi 
value of 0.877. At a threshold of 0.76, this patient would 
be classified as a 1; the patient reduces opiate usage. 
The percentage of “kept” OT, PT, and PM&R appointments 
is the only significant variable that is not involved in 
any interaction term (see Table 12). Moreover, the odds 
ratio value is greater than 1, meaning that more missed 
appointments decrease the likelihood of opiate reduction. 
Figure 15 illustrates that an amputee patient who maintains 
80% or less of their PT, OT, and PM&R appointments accounts 
for approximately 80% (27/34) of the patients who did not 
significantly reduce their opiate usage. Per the 
observations and analysis, there exists a positive 
association between an amputee patient’s ability to keep 




Figure 15.  The interaction of “kept” OT, PT, and PM&R 
appointments on a patient’s ability to reduce 
their opiate usage. There is a positive 
association between the amputee’s ability to keep 
their appointments and a reduction in their 
opiate usage. 
The presence of interaction in a logistic model can 
complicate the interpretation of an individual effect. For 
clarity of interpretation and results, we present 
descriptive statistics in tabular form as well as 
interaction plots. Tables 14 and 15 and Figures 16 through 
19 illustrate exploratory descriptive statistics of the 
interaction terms involved in the model. Patients were 
divided into four groups and broken down by reduction in 
opiate usage and race. Table 14 illustrates that there are 






























































No Significant Opiate Reduction
Significant Opiate Reduction
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twice as many Caucasian patients compared to non-Caucasian 
patients who significantly reduced their opiate usage and 
approximately the same number of patients who did not 
significantly reduce their opiate usage regardless of race 
(e.g., Caucasian patients who did reduce their opiate usage 
= 22, compared to non-Caucasian patients who did = 10). 
Significant Opiate Reduction by Age and Race 
AGE NO YES TOTAL 
 Caucasian Non-Caucasian Caucasian Non-Caucasian  
19-21 4 5 22 10 41 
22-24 6 7 24 16 53 
25-27 4 2 21 4 31 
OVER 27 5 1 17 9 32 
TOTAL 19 15 84 39 157 
Table 14.   Count of patients by reduction in opiate 
usage (YES) by age and race. 
The percentage of patients who display a greater 
reduction in opiate usage are 27–year-old (or younger at 
the time of entry into the C5 program) Caucasian patients, 
compared to non-Caucasian patients. The percentage 
declines, however, when the patient is older than 27 (as 
shown in Figure 16). 
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Figure 16.  Interaction of the patient’s age and race 
compared to the percentage of patients who display 
significant opiate reduction. The percentage of 
patients who display a greater reduction in opiate 
usage are 27-year-old (or younger) Caucasian patients 
compared to non-Caucasian patients. 
Figure 17 displays the interaction plot between age 
and race. We can also see that the overall estimated 
probability of reduction in opiate usage decreases as a 
Caucasian patient’s age increases, whereas the estimated 































































Figure 17.  Interaction plot of patient’s age and race. 
The estimated probability of reduction in opiate 
usage increases as a non-Caucasian patient ages. 
Table 15 illustrates that there are approximately five 
times as many patients with one or two primary diagnoses 
that reduced their opiate usage than those patients who did 
not (28:6, 35:7). There are also three times as many 
patients with three or more primary diagnoses that reduce 
their opiate usage than those who did not (30:10, 30:11). 
 
Significant Opiate Reduction by Number of Primary 
Conditions and Age 
#Primary 
Diagnosis 
1 2 3 Over 3 Total 
AGE YES NO YES NO YES NO YES NO   
19-21 8 3 8 3 9 2 7 1 41 
22-24 5 2 12 3 13 4 10 4 53 
25-27 7 1 7 0 5 2 6 3 31 
OVER 27 8 0 8 1 3 2 7 3 32 
TOTAL 28 6 35 7 30 10 30 11 157 
Table 15.   Count of patients by reduction in opiate 
usage (YES/NO) by age and number of  
primary diagnoses. 
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Figure 18 shows that patients between the ages of 22 
and 24 years old tend to maintain a relatively consistent 
percentage of reducing their opiate usage (70%-80%),  
regardless of the amount of primary diagnosis; whereas, the 
youngest patients (19-21 years old) tend to reduce opiate 
usage as the number of primary conditions increase. 
 
Figure 18.  Interaction of patient’s age and number of 
primary conditions compared to the percentage of 
patients who displayed a significant opiate 
reduction. There is greater variability in the 
percentage of patients with opiate reduction when 
the patient is 25 and older, as the number of 
primary conditions increases. 
We can also see that the overall estimated probability 
of reduction in opiate usage declines as the patient ages 




Figure 19.  Interaction plot of a patient’s age with the 
number of primary conditions. The estimated 
probability of reduction in opiate usage declines 
as the patient ages and the number of primary 
conditions increases. 
Our model is based on 157 observational data points. 
The percentage of kept appointments and the interaction of 
race and age, and the number of primary conditions and age 
appear to be correlated with whether or not a patient 
reduces their opiate usage. 
The observational data is moderately-sized. Therefore, 
it is possible that some of the model terms are sample-
specific and could not be generalized for the entire 
amputee population. For example, the empirical odds ratio 
of the influence of race on opiate usage is 1.7 by  
Equation 4. This implies that the odds of a patient 
decreasing their opiate usage is twice as high if the 
patient is Caucasian, than if the patient is not Caucasian. 
 
      |          
       |          
   
      |              







 = 1.7    (4) 
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Due to the relatively small number of patients who are 
not Caucasian and did not significantly reduce their opiate 
usage (15 patients), the empirical odds ratio can be 
altered by a small decrease of patients falling into this 
group. For example, by simply having nine (a reduction of 
six patients) non-Caucasian patients who did not 
significantly reduce their opiate usage, the new empirical 
odds ratio is approximately 1. This suggests that the odds 
of an amputee patient who is Caucasian or not is equally 
likely to reduce opiate usage over time. 
While few studies were found that directly impact the 
research direction for Model 1, a study of opiate 
medication usage for treatment of chronic pain by Trevino 
et al. (2013) found that trauma patients medicated with 
narcotics at four months posttrauma had significantly more 
depression and anxiety. Our model suggests that there is a 
positive correlation to a reduction in opiate usage and 
percentage of kept physical rehabilitation appointments. 
Therefore, promoting compliance with PT, OT, and PM&R 
appointments could improve the mental health outcome of 
patients. The goal of patient care is overall health 
improvement, both physically and mentally, of the patient. 
Our study could be used for future meta-analysis work 
to determine if similar correlations are repeated in other 
amputee populations. 
B. MODEL 2 
Do patient demographics and/or percentage of 
“cancelled” appointments correlate with their duration in 
the C5 program? 
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1. Analytical Method 
Model 2 analyzes the relationship between patient 
demographics and cancelled appointment rates, and an 
amputee’s duration in the C5 program (measured in days). A 
multiple linear regression model is used in this case, as 
the outcome of “duration” is a continuous variable. 
A multiple linear regression models the association 
between at least two exploratory variables   and a response 
variable   by fitting a linear equation to the observed data 
(Lacey, 1997). The population regression line describes how 
the mean (     ) changes with respect to the exploratory 
variables; the theoretical model with only main effects is 
represented as: 
 




   = The dependent variable for every observation 
( ), duration in the C5 program (in days) 
 
   = Intercept 
 
     = Estimated coefficient (slope) for each 
independent variable 
 
  = Values of exploratory variables (regressors) 
 
  = Residuals 
 
The observed values for y are assumed to have the same 
standard deviation and fluctuate about the mean E[   . The 
estimates of the population regression line are   ,      . 
The residual term (or noise) in the data, notated by  , 
represents the difference between the observed values   from 
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their means E    , which are assumed to have a mean of zero, 
constant variance, and to be normally distributed (Lacey, 
1997). 
The coefficients in the model represent the change in 
dependent variable for a unit change in  . The      included 
in this model are shown in Table 6. 
2. Analysis 
To analyze Model 2, the data is fit utilizing a 
multivariate Linear Model (LM) in R, allowing for two-way 
interactions of the independent variables using the StepAIC 
function. Initial testing indicated that subcategorizing 
the patients by type of amputation: UEA, LEA, or both (an 
upper- and lower-body extremity amputation) led to a 
superior model fit. 
A   transformation is required in the model because the 
residuals were not normally distributed. We used a Box-Cox 
test to determine a   transformation of   .   was 
approximately 0.5, which translates to a transformation of   
to √  (see Appendix C for   transformation test and model 
selection). After several iterations of model fitting, the 
model with coefficients shown in Table 16 was used (see 
Appendix C for the R-code). Parameter estimates involving 
categorical values require the addition of dummy variables. 
For example, the variable “location of amputation” has 
three categories (upper, lower, and both). The dummy 
variables in the model are upper and lower, while the 
category “both” is associated with the intercept value of 
the model. While the overall effect is significant, not all 
 53 
dummy variables necessarily appear as significant or have a 
p-value of 0.05. 
TERM Estimate Std. Error t value Pr(>|t|) 
INTERCEPT 20.896 8.2039 2.547 0.01176* 
AGE_ENTRY -0.2638 0.1172 -2.251 0.02566* 
CAUSE_IED -2.9997 3.0794 -0.974 0.33139 
NUM_PRIMARY 1.5969 0.6705 2.382 0.01835* 
CAUCASIAN_1 -6.2217 5.0935 -1.222 0.22360 
PerCNL 0.1707 0.3595 0.475 0.63561 
AMP_SITE_L 9.9775 6.8490 1.457 0.14704 





















PerCNL: AMP_SITE_L -0.4017 0.3213 -1.250 0.21301 






















‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 
Table 16.   Regression of Model 2. 
The final model can be expressed in Equations 5 and 6: 
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                                                            (6) 
The R-squared and adjusted R-squared value of Model 2 
are 0.2500 and 0.1932, respectively; 19% of the variance is 
explained by this model. The residuals of the model are 
homoscedastic, independent, and normally distributed. 
3. Results and Discussion 
While our model does not prove causation, it does 
provide insight into exploratory variable and response 
correlations. 
The fitted model shown in Equation 6 indicates that 
the slopes of the main effect coefficients for a patient’s 
age, IED injury, and race are negative. This implies that 
the presence of an IED injury or being a Caucasian patient 
decreases the patient’s duration in the program. It also 
suggests that as a patient’s age increases, their duration 
in the program declines, whereas the coefficients for the 
number of primary conditions and percentage of cancelled 
appointments are positive. As the number of primary 
conditions and percentage of cancelled appointments 
increase, patients are staying in the program longer. 
Figure 20 indicates the interpretation of the amputee 
location variable (AMP_SITE_L and AMP_SITE_U). Recall that 
the response  ̂  is the square root of the days in the 
program. Our model predicts that a patient with an upper-
body amputation spends approximately 225 days in the 
 55 
program, compared to 900 days for a patient with a lower-
body amputation (holding all other variables constant). 
 
Figure 20.  Amputation site coefficient estimates for 
the fitted model for y. Amputees with lower-body 
amputations spend the most time in the program. 
Additionally, the interaction of exploratory variables 
influences the coefficient estimates. Figures 21 through 24 
display interaction plots of the exploratory variables in 
the fitted model. 
When a Caucasian patient cancels more appointments, 
their duration in the program declines. There is, however, 
a positive correlation between the percentage of cancelled 
appointments and duration in the program for non-Caucasian 
patients (see Figure 21). Notice that the slopes of the 
lines in the interaction plot are in opposite directions. 
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Figure 21.  Interaction plot between race and the 
percentage of “cancelled” appointments from  
Model 2. There is a positive correlation between 
the percentage of “cancelled” appointments and 
duration in the program for non-Caucasian 
patients and a negative correlation for  
Caucasian patients. 
The interaction plot in Figure 22 has two lines with 
opposing slope directions. This implies that as a patient 
with an IED injury increases their percentage of 
“cancelled” appointments and their duration in the program 
increases, whereas a patient without an IED-inflicted 
amputation remains in the program for less time as the 
percentage of “cancelled” appointments increases. 
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Figure 22.  Interaction plot between the patient’s 
mechanism of injury and the percentage of 
“cancelled” appointments. IED-injured patients 
with a greater percentage of “cancelled” 
appointments are positively correlated to a 
longer duration in the program. 
Figure 23 displays the interaction between the 
patient’s mechanism of injury and the number of primary 
conditions. When a patient suffers from an IED-related 
amputation, their duration in the program is relatively 
constant (almost a horizontal slope), regardless of the 
number of primary conditions. When a patient does not 
suffer from an IED-related amputation, however, there is a 
greater variation in the patient’s duration in the program 
across the magnitude of primary conditions. Specifically, 
patients without an IED-related injury spend more time in 




Figure 23.  Interaction plot between the mechanism of 
injury and number of primary conditions from 
Model 2. Patients without an IED-related injury 
spend more time in the C5 program as the number 
of primary conditions increases. 
In Figure 24, notice that the direction of the slopes 
for UEAs and amputees with both an LEA and UEA are 
positive. This implies that as the percentage of 
“cancelled” appointments increases, UEAs and amputees with 
both an LEA and UEA spend more time in the C5 program 
(days). This is in contrast to amputees with lower-body-
extremity amputation, who spend less time in the C5 program 
as the percentage of “cancelled” appointments increase. 
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Figure 24.  Interaction plot between the amputation site 
and the percentage of “cancelled” appointments 
from Model 2. As the percentage of “cancelled” 
appointments increases, UEAs and amputees with 
both an LEA and UEA spend more time in the C5 
program (days). 
Model 2 is based on 182 patients. Our analysis shows 
that the amputation site influences treatment longevity. 
There is a distinct difference between the amputation site 
and its correlation to treatment duration. Recall that as 
the percentage of “cancelled” appointments increased, UEAs 
and amputees with both an LEA and UEA spent more time in 
the C5 program (days), whereas lower-body-extremity 
amputation patients did not. While few studies were found 
that directly impact the research direction for Model 2, a 
study by Shin et al. (2012) found that UEAs were associated 
with increased injury severity and HLOS and ILOS. Our study 
produces similar results with UEA patients staying in the 
C5 program longer in the presence of increased “cancelled” 
appointments. LEA patients as a whole, however, spend more 
time in the treatment program (recall Figure 20). HLOS and 
ILOS were not included in this study. This suggests that 
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UEAs and those with both a UEA and LEA are more affected by 
“cancelled” appointments than LEAs in terms of completing 
their treatment. 
We see that “cancelled” appointment rates are 
positively associated with an amputee patient’s duration in 
the C5 program when the patient is non-Caucasian, has an 
IED injury, or has a UEA or both an LEA and UEA. Recall 
that the data are not sufficiently robust to support a 
clear distinction in defining “cancelled” and “no show” 
appointments. For example, many “cancelled” appointments 
were terminated on the same day of the scheduled 
appointment. Appointment status is manually entered; 
therefore, the presence of human error could bias the 
impact of “no show” rates if appointments were noted as 
“cancelled,” but were truly a “no show.” Appointments 
cancelled on the same day or within the same hour of 
scheduled care increase medical costs through wasted 
physician man-hours and more days of patient treatment 
through rescheduled appointments. This leads to 
underutilized resources, poor medical outcomes as untreated 
conditions worsen, and denied care to other patient’s 
(Bertrand, 2000). Therefore, implementing programs or 
incentives that discourage patients from missing their 
appointments can increase treatment efficiency and resource 
utilization. Future research in patient-provider modeling 
that focuses on optimizing the ratio of appointment types 
(e.g., what is the optimal amount of primary care, PT, OT, 
etc. appointment mix that renders an optimal medical 




In an effort to better understand the factors that 
influence the treatment effectiveness of combat casualty 
amputee patients, our thesis analyzed the data of 182 
amputee patients within the C5 program through the use of 
logistic and linear regression models. 
The main results of our analysis show that: 
 An increase in attendance to PT, OT, and PM&R 
appointments correlated to an increased 
likelihood of reduced opiate usage. 
 The estimated probability of reduction in opiate 
usage is less likely as the patient ages and the 
number of primary medical conditions increase. 
 Patients without an IED injury spend more time in 
the program as the number of primary conditions 
increase. 
 The percentage of cancelled appointments is 
positively associated with the treatment duration 
of UEAs, patients with both a UEA and LEA, and 
amputations caused by an IED. 
 The number of follow-up surgeries, the presence 
of a traumatic brain injury, and possessing a 
mental health condition did not have a 
significant impact on opiate usage or duration in 
the program. 
A. FUTURE RESEARCH 
The results of our study and similar studies can 
influence medical cost-saving initiatives and practices by 
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analyzing the implications of treatment compliance, 
effective treatment programs, and understanding 
prescription drug utilization. For example, many private 
medical practices charge a fee for not showing up at all or 
cancelling an appointment within 24 hours of scheduled care 
to deter patients from missing their appointments. Military 
medicine could implement a similar fee to discourage missed 
appointments, which lessens medical resource waste. Our 
study also did not distinguish between which types of 
appointments were missed most often and the location of 
care. It is not uncommon for specialty appointments to be 
located off-site from the MTF, whereas primary care is 
generally located on-site. The location of the appointment 
may influence the number of missed appointments, as those 
appointments that are missed most often may reflect care 
that is provided off-site, where the means of 
transportation could create an undue burden on the patient. 
Providing optional means of transportation, such as a 
shuttle service, could increase appointment compliance. 
Our study could be used for future meta-analysis work 
to determine if similar correlations are repeated in other 
amputee populations by collecting a larger sample size of 
amputee patient data from multiple MTFs. It may also be 
useful to formulate an injury severity score of the amputee 
patient prior to entry into the C5 program and include this 
score in the models. The injury severity score could 
include data relevant to the severity of an injury such as: 
 Patients hospital and intensive care length  
of stay; 
 Amount of blood products used in treatment; 
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 Presence of infection, anemia, pulmonary 
embolism, and septicemia; 
 Severity of amputation; 
 Preexisting medical conditions; and 
 Surgical and nonsurgical treatment from point of 
injury (level 1 trauma care) to a U.S. MTF (level 
5 trauma care). 
Our study focused solely on opiate usage; however, 
there are numerous medications prescribed to amputee 
patients for pain management or management of other 
symptoms including (but not limited to): nonsteroidal anti-
inflammatory medications, centrally acting skeletal muscle 
relaxants, and anticonvulsants. 
Future analysis could study the implications of other 
types of drug usage on physical and mental rehabilitations. 
The impact of appointment statistics and prescription 
compliance could be expanded to other areas of treatment, 
such as those patients who suffer from only a TBI or PTSD. 
For example, do patient demographics and/or the number of 
attended mental health appointments correlate with reduced 
antidepressant medication usage? Lastly, more research in 
patient-provider modeling that focuses on optimizing the 
ratio of appointment types (e.g., what is the optimal 
amount of primary care, PT, OT, etc. appointment mix that 
renders an optimal medical outcome) could also reduce the 
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APPENDIX A. R-CODE FOR MODEL 1 RESPONSE VARIABLE 
R-code for Simple Linear Regression: To determine the 
response variable for Model 1 (Opiate Medication Declines 
over Treatment Phase in Amputee Patients). 
R-code and Output 
#OpiateUsage is a dataframe containing QTY~ Quantity of 
#opiates dispensed and DaysFromStart_D ~ number of days 
#that have elapsed between the patients start date in the 
#C5 program and date of dispensed medication. 
 





lm(QTY~DaysFromStart_D, data = OP2)  
anova(lm(QTY~DaysFromStart_D, data = OP2)) 
 
#Function to calculate Pr(>F) values on simple linear 
#regression model of: Frequency of Opiate Medication(y) = 
#DaysFromStart_D (Date of entry into program from 
#prescription “Dispense” date ~x) 
 
Sig<-function(x) { 
 if (nrow(x)>2){ 
  xx <-anova(lm(QTY~DaysFromStart_D, data = x)) 
  xx[[1,'Pr(>F)']] 
 } 
 else 1 
# must have at least 3 data points (3 prescribed and 
# dispensed opiate medications per patient) for ANOVA or 
# result is 1 
} 
 
#Run the function “SIG” on each patient but break-up output 
#by patient “Episode ID” ~ return Pr(>F) values 
 






#simple linear model 
 




lm(formula = QTY ~ DaysFromStart_D, data = OP2) 
 
Coefficients: 
  (Intercept) DaysFromStart_D  
     88.683      -1.078  
 
#ANOVA on LM model 
#look at single patient 
 
anova(lm(QTY~DaysFromStart_D, data = OP2))  
 
OUTPUT 
#output for single patient, Patient 2 
#Accept NULL Hypothesis for Patient 2 
 
Analysis of Variance Table 
 
Response: QTY 
        Df Sum Sq Mean Sq F value Pr(>F) 
DaysFromStart_D 1 310.42 310.42 0.7699 0.4448 
Residuals    3 1209.58 403.19   
 
#run the regression for the first 4 patients  
#Note: accept Null Hypothesis for all 4 patients 
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APPENDIX B. LOGISTIC REGRESSION R-CODE FOR MODEL 1 
Utilizing R StepAIC with two-way interaction 
(Factorial to degree 2) resulted in the following Logistic 
Regression Model. 
R-code For Model 1 
#main effects model using a GLM, data is called “OP” 
 
OP0<-glm 
  (Reduce_Opiate_Dis~AGE_ENTRY+TBI+Num_Primary+PER_KEPT + 
   Caucasian+X.Fol_Up_Surgeries+M_Health + AMP_SITE, 
data=OP,  
   family =binomial) 
 
#main effect model with two way interactions 
 





#output from OP_ALT 
 
Call: 
glm(formula = Reduce_Opiate_Dis ~ AGE_ENTRY + Num_Primary + 
PER_KEPT + Caucasian + AGE_ENTRY:Num_Primary + 
AGE_ENTRY:Caucasian, family = binomial, data = OP) 
 
Deviance Residuals:  
  Min    1Q  Median    3Q   Max  
-2.1504  0.2893  0.5157  0.7030  1.4622  
Coefficients: 
        Estimate Std. Error z value Pr(>|z|)   
(Intercept)  -11.37162  4.39121 -2.590 0.00961 ** 
AGE_ENTRY    0.41635  0.17326  2.403 0.01626 *  
Num_Primary   2.03794  1.05483  1.932 0.05336 .  
PER_KEPT    0.04074  0.01715  2.375 0.01754 *  
Caucasian1   7.20007  2.82198  2.551 0.01073 *  
AGE_ENTRY:Num_Primary 
        -0.09379  0.04358 -2.152 0.03138 *  
AGE_ENTRY:Caucasian1 
        -0.26966  0.11649 -2.315 0.02062 *  
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’  
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#Misclassification rate, Confusion Matrix 
 
y1<-OP$Reduce_Opiate_Dis 
pi.hat1<-predict(OP_ALT, type = "response") 
 
#change thresholds here for threshold picture  
#top is false positive, bottom is false negative 
 
table(y1,pi.hat1 > .76)  
 
#Cross Validate Model, install BOOT package 
 
OP_ALT2.cv<-function(y1, pi.hat1) mean(y1 != (pi.hat1>.76))  
cv.glm(OP, OP_ALT, OP_ALT2.cv, K=10)$delta  
 
#for threshold picture 
#to find false positive and false negative values alter 
#threshold from: .9, .8, .7, .6, .5 
#prefer threshold of 0.76 to lower false positive rates 






#plot threshold picture 
 
plot(false.neg, false.pos, col = c("red", "orange", 
"yellow", "green", "blue"), pch=c(21,15,19,22,17),ylab = 
"False Positive", xlab="False Negative", main="Variation of 
Reduction in Opiate Usage Prediction Threshold 
Value")legend(locator(1),c("Threshold = .9", "Threshold = 
.8", "Threshold = .7","Threshold = .6", "Threshold = .5"), 





APPENDIX C. LINEAR REGRESSION R-CODE FOR MODEL 2 
Utilizing R StepAIC with two-way interaction 
(Factorial to degree 2) and drop 1 resulted in the 
following Multiple Linear Regression Model. 
#Dataset is called NSData with exploratory variables:  
#Cause_IED, #M_health, TBI, Caucasian, Amp_Site are 
#categorical and/or binary ~ reflected below 
 
NSData$Cause_IED = as.factor(NSData$Cause_IED) 
NSData$M_Health = as.factor(NSData$M_Health) 
NSData$TBI = as.factor(NSData$TBI) 
NSData$Caucasian = as.factor(NSData$Caucasian) 
NSData$Amp_Site = as.factor(NSData$Amp_Site) 
 
#perform BOX COX test for y-transformation 
 
boxcox(Duration_N_Prog~.,data= NSData) #yes y = sqrt(y) 
 
 







Y transformation from 
Box-Cox Analysis. 
 
λ is approximately 
0.5. 
 
#change y in csv 
#initial model with transformed y to sqrt (y) 
 






#stepAIC function with two-way interactions 
 
M2B<-stepAIC(M2b.LM, direction = "both,” trace = F) 
summary(M2B) 
 





#result of single term deletions (drop 1 function) 
 
Model: 
Duration_N_Prog ~ AGE_ENTRY + Cause_IED + Num_Primary + 
Caucasian + PerCNL + Amp_Site + Caucasian:PerCNL + 
AGE_ENTRY:Caucasian + PerCNL:Amp_Site + Cause_IED:PerCNL + 
Cause_IED:Num_Primary 
 
          Df Sum of Sq  RSS  AIC Pr(>Chi)   
<none>              5714.6 655.31       
Caucasian:PerCNL  1  173.06 5887.7 658.74 0.019796 *  
AGE_ENTRY:Caucasian 1  279.96 5994.6 662.02 0.003174 ** 
PerCNL:Amp_Site   2  332.12 6046.8 661.60 0.005853 ** 
Cause_IED:PerCNL  1  180.65 5895.3 658.98 0.017315 *  
Cause_IED:Num_Primary 
          1  170.57 5885.2 658.67 0.020690 *  
--- 




FinM2<-lm(Duration_N_Prog ~ AGE_ENTRY + Cause_IED + 
Num_Primary + Caucasian + PerCNL + Amp_Site + 
Caucasian:PerCNL + AGE_ENTRY:Caucasian + PerCNL:Amp_Site + 















#final Model 2 output 
 
Call: 
lm(formula = Duration_N_Prog ~ AGE_ENTRY + Cause_IED + 
Num_Primary + Caucasian + PerCNL + Amp_Site + 
Caucasian:PerCNL + AGE_ENTRY:Caucasian + PerCNL:Amp_Site + 
Cause_IED:PerCNL + Cause_IED:Num_Primary, data = NSData) 
 
Residuals: 
   Min    1Q  Median    3Q   Max  
-19.6398 -2.6525 -0.0741  2.5594 19.6948  
 
Coefficients: 
        Estimate Std. Error t value Pr(>|t|)   
(Intercept)   20.8960   8.2039  2.547 0.01176 *  
AGE_ENTRY    -0.2638   0.1172 -2.251 0.02566 *  
Cause_IED1    -2.9997   3.0794 -0.974 0.33139   
Num_Primary    1.5969   0.6705  2.382 0.01835 *  
Caucasian1    -6.2217   5.0935 -1.222 0.22360   
PerCNL      0.1707   0.3595  0.475 0.63561   
Amp_SiteL     9.9775   6.8490  1.457 0.14704   
Amp_SiteU    -4.7774   7.7431 -0.617 0.53808   
Caucasian1:PerCNL 
         -0.3324   0.1474 -2.256 0.02539 *  
AGE_ENTRY:Caucasian1 
         0.4833   0.1685  2.869 0.00465 ** 
PerCNL:Amp_SiteL -0.4017   0.3213 -1.250 0.21301   
PerCNL:Amp_SiteU 0.1328   0.3612  0.368 0.71352   
Cause_IED1:PerCNL 0.3273   0.1420  2.304 0.02242 *  
Cause_IED1:Num_Primary 
         -1.7684   0.7897 -2.239 0.02645 *  
--- 
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 
Residual standard error: 5.832 on 168 degrees of freedom 
Multiple R-squared: 0.2512, Adjusted R-squared: 0.1932 
F-statistic: 4.334 on 13 and 168 DF, p-value: 2.832e-06 
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